For instance, adropin treatment has been shown to enhance insulin sensitivity, ameliorate insulin resistance, and promote glucose utilization while suppressing fatty acid oxidation, thus favoring a metabolic shift toward carbohydrate metabolism [80,82,88]. Here, ENHO is linked to Insulin resistance.